Filing Details

Accession Number:
0001462830-25-000001
Form Type:
13G Filing
Publication Date:
2025-03-10 20:00:00
Filed By:
Iliad Research & Trading, L.P.
Company:
Cardiogenics Holdings Inc. (OTCMKTS:CGNH)
Filing Date:
2025-03-11
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
Iliad Research & Trading, L.P. 0 2,415,275 9.9%
Iliad Management, LLC 0 2,415,275 9.9%
Fife Trading, Inc. 0 2,415,275 9.9%
John M Fife 0 2,415,275 9.9%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  Reporting Person Iliad Research & Trading, LP ("Iliad") has rights to convert a Promissory Note into shares of the Issuer's common stock. On the date of the event which requires filing this statement, the number of shares of the Issuer's common stock beneficially owned by Iliad was 2,415,275 shares, which represents the maximum percentage ownership allowed under the terms of the Secured Convertible Promissory Note in effect on that date. The 2,415,275 shares represent 9.99% of the 24,176,927 shares outstanding on that date (as reported in the Issuer's Form 10-Q filed March 24, 2015).


SCHEDULE 13G



Comment for Type of Reporting Person:  Iliad Management, LLC is the general partner of reporting person Iliad. Iliad has rights to convert a Promissory Note into shares of the Issuer's common stock. On the date of the event which requires filing this statement, the number of shares of the Issuer's common stock beneficially owned by Iliad was 2,415,275 shares, which represents the maximum percentage ownership allowed under the terms of the Secured Convertible Promissory Note in effect on that date. The 2,415,275 shares represent 9.99% of the 24,176,927 shares outstanding on that date (as reported in the Issuer's Form 10-Q filed March 24, 2015).


SCHEDULE 13G



Comment for Type of Reporting Person:  Fife Trading, Inc. is the manager of Iliad Management, LLC, which is the general partner of reporting person Iliad. Iliad has rights to convert a Promissory Note into shares of the Issuer's common stock. On the date of the event which requires filing this statement, the number of shares of the Issuer's common stock beneficially owned by Iliad was 2,415,275 shares, which represents the maximum percentage ownership allowed under the terms of the Secured Convertible Promissory Note in effect on that date. The 2,415,275 shares represent 9.99% of the 24,176,927 shares outstanding on that date (as reported in the Issuer's Form 10-Q filed March 24, 2015).


SCHEDULE 13G



Comment for Type of Reporting Person:  John Fife is the president of Fife Trading, Inc. which is the manager of Iliad Management, LLC, which is the general partner of reporting person Iliad. Iliad has rights to convert a Promissory Note into shares of the Issuer's common stock. On the date of the event which requires filing this statement, the number of shares of the Issuer's common stock beneficially owned by Iliad was 2,415,275 shares, which represents the maximum percentage ownership allowed under the terms of the Secured Convertible Promissory Note in effect on that date. The 2,415,275 shares represent 9.99% of the 24,176,927 shares outstanding on that date (as reported in the Issuer's Form 10-Q filed March 24, 2015).


SCHEDULE 13G


 
Iliad Research & Trading, L.P.
 
Signature:John Fife
Name/Title:President
Date:03/11/2025
 
Iliad Management, LLC
 
Signature:John Fife
Name/Title:President
Date:03/11/2025
 
Fife Trading, Inc.
 
Signature:John Fife
Name/Title:President
Date:03/11/2025
 
John M Fife
 
Signature:John Fife
Name/Title:John Fife
Date:03/11/2025